Blood Cell Clues Reveal Who Benefits When Radiotherapy Meets Immunotherapy in Lung Cancer
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
A propensity score matched study from Taiwan finds that adding the immunotherapy drug nivolumab to definitive chemoradiotherapy tripled median overall ...
A detailed case report documents a 30-year-old man with BRD4::NUTM1 fusion laryngeal NUT carcinoma who survived four years while every ...
A retrospective real-world study found that neoadjuvant chemoimmunotherapy followed by surgery produced significantly longer overall survival and strong pathologic responses ...
A new Nature Protocols paper details a mussel-inspired dopamine polymerization technique that coats living bacteria with therapeutic molecules to combat ...
Final Phase 3 IMpower030 results show that perioperative atezolizumab plus chemotherapy extended median event-free survival to 62.8 months versus 34.9 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine